Most Read Articles
Dr. Joseph Delano Fule Robles, 14 Nov 2017

A recent study conducted by The University of Hong Kong (HKU) revealed that long-term use of proton pump inhibitors (PPIs) is associated with a significantly increased risk of gastric cancer even in patients who have had Helicobacter pylori eradicated. 

14 Nov 2017
The 5-year survival rates for human papillomavirus (HPV)-associated cancers vary greatly according to age and race, with Caucasians and younger patients tending to have better survival, according to a recent US study.
6 days ago
Both hatha yoga and a low-FODMAP (Fermentable, Oligo-, Di-, Monosaccharides and Polyol) diet can alleviate gastrointestinal symptoms, as well as improve a range of other psychological and physiological health parameters, in patients with irritable bowel syndrome (IBS), a study has shown.
6 days ago
Men with breast cancer have tumours that are typically of the human epidermal growth factor receptor 2-negative Luminal B subtype and positive for oestrogen receptor, progesterone receptor and androgen receptor, according to the results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program study.

Major GI bleeding risk similar between NOACS and conventional anticoagulation

19 May 2017

Nonvitamin K antagonist oral anticoagulants (NOACs) appear to pose a risk of major gastrointestinal (GI) bleeding that is similar to that with conventional anticoagulation, according to a systematic review and meta-analysis. On the other hand, dabigatran and rivaroxaban are associated with increased risk of major GI bleeding.

Researchers searched electronic databases for randomized trials evaluating NOACs vs conventional anticoagulants for approved indications. A total of 43 trials were included, yielding a population of 166,289 patients. The main outcome was major GI bleeding, while secondary outcomes were clinically relevant nonmajor bleeding and upper and lower GI bleeding.

Pooled data showed no difference between NOACs and conventional anticoagulants in the risk of major bleeding (1.5 vs 1.3 percent; odds ratio [OR], 0.98; 95 percent CI, 0.80 to 1.21), clinically relevant nonmajor bleeding (0.6 vs 0.6 percent; OR, 0.93; 0.64 to 1.36), upper GI bleeding (1.5 vs 1.6 percent; OR, 0.96; 0.77 to 1.20) or lower GI bleeding (1.0 vs 1.0 percent; OR, 0.88; 0.67 to 1.15).

However, both dabigatran and rivaroxaban were found to have greater odds of major GI bleeding compared with conventional anticoagulation (dabigatran: 2.0 vs 1.4 percent; OR, 1.27; 1.04 to 1.55 and rivaroxaban: 1.7 vs 1.3 percent; OR, 1.40; 1.15 to 1.70). No difference was observed with apixaban (0.6 vs 0.7 percent; OR, 0.81; 0.64 to 1.02) or edoxaban (1.9 vs 1.6; OR, 0.93; 0.78 to 1.11). These subgroup findings did not persist in other sensitivity analyses.

The present data suggest that while NOACs do not differ with conventional anticoagulation in terms of major GI bleeding risk, dabigatran and rivaroxaban may particularly be associated with greater odds of major GI bleeding. In light of this, additional high-quality studies are needed to characterize GI bleeding risk among NOACs, researchers said.

Unlike vitamin K antagonists, NOACs (eg, apixaban, dabigatran, edoxaban and rivaroxaban) are convenient, as they dismiss the need of regular checking of haemostatic parameters. Moreover, NOACs have been shown to reduce the risk of major bleeding, intracranial haemorrhage in particular. GI bleeding is the most frequent cause of major bleeding, attributed to 30 to 40 percent of such events. [Aliment Pharmacol Ther 2015;42:1239–1249]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 14 Nov 2017

A recent study conducted by The University of Hong Kong (HKU) revealed that long-term use of proton pump inhibitors (PPIs) is associated with a significantly increased risk of gastric cancer even in patients who have had Helicobacter pylori eradicated. 

14 Nov 2017
The 5-year survival rates for human papillomavirus (HPV)-associated cancers vary greatly according to age and race, with Caucasians and younger patients tending to have better survival, according to a recent US study.
6 days ago
Both hatha yoga and a low-FODMAP (Fermentable, Oligo-, Di-, Monosaccharides and Polyol) diet can alleviate gastrointestinal symptoms, as well as improve a range of other psychological and physiological health parameters, in patients with irritable bowel syndrome (IBS), a study has shown.
6 days ago
Men with breast cancer have tumours that are typically of the human epidermal growth factor receptor 2-negative Luminal B subtype and positive for oestrogen receptor, progesterone receptor and androgen receptor, according to the results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program study.